Ghost Tree Capital »

Rezolute shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.2M 1.5M 4.85
2024-06-30 $6.1M 1.4M 4.30

More positions owned by Ghost Tree Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Biohaven Call
Sarepta Therapeutics (SRPT)
Novo-nordisk A S Adr (NVO)
Blueprint Medicines (BPMC)
Axsome Therapeutics (AXSM)
Tarsus Pharmaceuticals (TARS)
Perspective Therapeutics Com New (CATX)
Cg Oncology (CGON)
Roivant Sciences SHS (ROIV)
Vaxcyte (PCVX)
Insmed Com Par $.01 (INSM)
Viking Therapeutics (VKTX)
Syndax Pharmaceuticals (SNDX)
Janux Therapeutics (JANX)

View all positions for Ghost Tree Capital

Top funds holding Rezolute

Federated Investors
Nantahala Capital Management
Vivo Capital
Adage Capital Partners GP
Vanguard Group
Blackstone Group
Altium Capital Management
Affinity Asset Advisors
ADAR1 Capital Management
Ghost Tree Capital
Caxton
Sphera Funds Management
Woodline Partners
Susquehanna International
Ikarian Capital

View all funds holding Rezolute